289 related articles for article (PubMed ID: 28225648)
1. Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury.
Anderson KD; Guest JD; Dietrich WD; Bartlett Bunge M; Curiel R; Dididze M; Green BA; Khan A; Pearse DD; Saraf-Lavi E; Widerström-Noga E; Wood P; Levi AD
J Neurotrauma; 2017 Nov; 34(21):2950-2963. PubMed ID: 28225648
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 Safety Trial of Autologous Human Schwann Cell Transplantation in Chronic Spinal Cord Injury.
Gant KL; Guest JD; Palermo AE; Vedantam A; Jimsheleishvili G; Bunge MB; Brooks AE; Anderson KD; Thomas CK; Santamaria AJ; Perez MA; Curiel R; Nash MS; Saraf-Lavi E; Pearse DD; Widerström-Noga E; Khan A; Dietrich WD; Levi AD
J Neurotrauma; 2022 Feb; 39(3-4):285-299. PubMed ID: 33757304
[TBL] [Abstract][Full Text] [Related]
3. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
[TBL] [Abstract][Full Text] [Related]
4. Scalable culture techniques to generate large numbers of purified human Schwann cells for clinical trials in human spinal cord and peripheral nerve injuries.
Khan A; Diaz A; Brooks AE; Burks SS; Athauda G; Wood P; Lee YS; Silvera R; Donaldson M; Pressman Y; Anderson KD; Bunge MB; Pearse DD; Dietrich WD; Guest JD; Levi AD
J Neurosurg Spine; 2022 Jan; 36(1):135-144. PubMed ID: 34479193
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes.
Saberi H; Moshayedi P; Aghayan HR; Arjmand B; Hosseini SK; Emami-Razavi SH; Rahimi-Movaghar V; Raza M; Firouzi M
Neurosci Lett; 2008 Sep; 443(1):46-50. PubMed ID: 18662744
[TBL] [Abstract][Full Text] [Related]
6. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
[TBL] [Abstract][Full Text] [Related]
7. Schwann Cell Transplantation Subdues the Pro-Inflammatory Innate Immune Cell Response after Spinal Cord Injury.
Pearse DD; Bastidas J; Izabel SS; Ghosh M
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30154346
[TBL] [Abstract][Full Text] [Related]
8. Autologous olfactory ensheathing cell transplantation in human spinal cord injury.
Féron F; Perry C; Cochrane J; Licina P; Nowitzke A; Urquhart S; Geraghty T; Mackay-Sim A
Brain; 2005 Dec; 128(Pt 12):2951-60. PubMed ID: 16219671
[TBL] [Abstract][Full Text] [Related]
9. Schwann cell transplantation for spinal cord injury repair: its significant therapeutic potential and prospectus.
Kanno H; Pearse DD; Ozawa H; Itoi E; Bunge MB
Rev Neurosci; 2015; 26(2):121-8. PubMed ID: 25581750
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Schwann cell transplantation for spinal cord repair is improved with combinatorial strategies.
Bunge MB
J Physiol; 2016 Jul; 594(13):3533-8. PubMed ID: 26876753
[TBL] [Abstract][Full Text] [Related]
11. Human Schwann cells exhibit long-term cell survival, are not tumorigenic and promote repair when transplanted into the contused spinal cord.
Bastidas J; Athauda G; De La Cruz G; Chan WM; Golshani R; Berrocal Y; Henao M; Lalwani A; Mannoji C; Assi M; Otero PA; Khan A; Marcillo AE; Norenberg M; Levi AD; Wood PM; Guest JD; Dietrich WD; Bartlett Bunge M; Pearse DD
Glia; 2017 Aug; 65(8):1278-1301. PubMed ID: 28543541
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of rat Schwann cells and 17β-estradiol in a spinal cord injury model.
Namjoo Z; Moradi F; Aryanpour R; Piryaei A; Joghataei MT; Abbasi Y; Hosseini A; Hassanzadeh S; Taklimie FR; Beyer C; Zendedel A
Metab Brain Dis; 2018 Aug; 33(4):1229-1242. PubMed ID: 29658057
[TBL] [Abstract][Full Text] [Related]
13. Targeting axonal degeneration and demyelination using combination administration of 17β-estradiol and Schwann cells in the rat model of spinal cord injury.
Namjoo Z; Mortezaee K; Joghataei MT; Moradi F; Piryaei A; Abbasi Y; Hosseini A; Majidpoor J
J Cell Biochem; 2018 Dec; 119(12):10195-10203. PubMed ID: 30129246
[TBL] [Abstract][Full Text] [Related]
14. From transplanting Schwann cells in experimental rat spinal cord injury to their transplantation into human injured spinal cord in clinical trials.
Bunge MB; Monje PV; Khan A; Wood PM
Prog Brain Res; 2017; 231():107-133. PubMed ID: 28554394
[TBL] [Abstract][Full Text] [Related]
15. Realizing the maximum potential of Schwann cells to promote recovery from spinal cord injury.
Bunge MB; Wood PM
Handb Clin Neurol; 2012; 109():523-40. PubMed ID: 23098734
[TBL] [Abstract][Full Text] [Related]
16. Reduction of cystic cavity, promotion of axonal regeneration and sparing, and functional recovery with transplanted bone marrow stromal cell-derived Schwann cells after contusion injury to the adult rat spinal cord.
Someya Y; Koda M; Dezawa M; Kadota T; Hashimoto M; Kamada T; Nishio Y; Kadota R; Mannoji C; Miyashita T; Okawa A; Yoshinaga K; Yamazaki M
J Neurosurg Spine; 2008 Dec; 9(6):600-10. PubMed ID: 19035756
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of Adult Rat Schwann Cells into the Injured Spinal Cord.
Dai Y; Hill CE
Methods Mol Biol; 2018; 1739():409-438. PubMed ID: 29546724
[TBL] [Abstract][Full Text] [Related]
18. Schwann cell transplantation for repair of the adult spinal cord.
Oudega M; Xu XM
J Neurotrauma; 2006; 23(3-4):453-67. PubMed ID: 16629629
[TBL] [Abstract][Full Text] [Related]
19. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
[TBL] [Abstract][Full Text] [Related]
20. Genetically modified Schwann cells producing glial cell line-derived neurotrophic factor inhibit neuronal apoptosis in rat spinal cord injury.
Liu G; Wang X; Shao G; Liu Q
Mol Med Rep; 2014 Apr; 9(4):1305-12. PubMed ID: 24549701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
